Corcept Therapeutics (CORT) Change in Account Payables (2010 - 2026)
Corcept Therapeutics recorded quarterly Change in Account Payables of -$7.6 million in Q1 2026, down 227.44% quarter-over-quarter from $6.0 million in Q4 2025, and down 160.81% year-over-year from $12.6 million in Q1 2025.
Corcept Therapeutics' Change in Account Payables history runs 17 years deep, the most recent figure standing at -$7.6 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 160.81% year-over-year to -$7.6 million; the TTM figure through Mar 2026 stood at $4.9 million (down 68.51% YoY), while the FY2025 annual figure was $25.1 million, up 1340.99% from the prior year.
- Change in Account Payables came in at -$7.6 million for Q1 2026 at Corcept Therapeutics, down from $6.0 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $12.6 million in Q1 2025 to a low of -$7.6 million in Q1 2026.
- A 5-year average of $1.5 million and a median of -$165000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 5303.03% in 2023 and sank 649.0% in 2024, its largest moves.
- Corcept Therapeutics' Change in Account Payables stood at $4.2 million in 2022, then slumped by 84.98% to $637000.0 in 2023, then tumbled by 587.6% to -$3.1 million in 2024, then soared by 293.11% to $6.0 million in 2025, then tumbled by 227.44% to -$7.6 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$7.6 million, $6.0 million, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn | -7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 10.92 Mn |
| Sep 30, 2025 | 10.92 Mn |
| Jun 30, 2025 | -4.42 Mn |
| Jun 30, 2025 | -4.42 Mn |
| Mar 31, 2025 | 12.57 Mn |
| Mar 31, 2025 | 12.57 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -649,000.00 |
| Sep 30, 2024 | -649,000.00 |
| Jun 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 6.60 Mn |
| Mar 31, 2024 | -4.86 Mn |
| Mar 31, 2024 | -4.86 Mn |
| Dec 31, 2023 | 637,000.00 |
| Dec 31, 2023 | 637,000.00 |
| Sep 30, 2023 | 8.59 Mn |
| Sep 30, 2023 | 8.59 Mn |
| Jun 30, 2023 | -3.15 Mn |
| Jun 30, 2023 | -3.15 Mn |
| Mar 31, 2023 | -649,000.00 |
| Mar 31, 2023 | -649,000.00 |
| Dec 31, 2022 | 4.24 Mn |
| Dec 31, 2022 | 4.24 Mn |
| Sep 30, 2022 | -165,000.00 |
| Sep 30, 2022 | -165,000.00 |
| Jun 30, 2022 | -1.58 Mn |
| Jun 30, 2022 | -1.58 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Dec 31, 2021 | 364,000.00 |
| Dec 31, 2021 | 364,000.00 |
| Sep 30, 2021 | -2.66 Mn |
| Sep 30, 2021 | -2.66 Mn |
| Jun 30, 2021 | 2.19 Mn |
| Jun 30, 2021 | 2.19 Mn |
| Mar 31, 2021 | -3.49 Mn |
| Mar 31, 2021 | -3.49 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Sep 30, 2020 | 263,000.00 |
| Sep 30, 2020 | 263,000.00 |
| Jun 30, 2020 | 1.35 Mn |
| Jun 30, 2020 | 1.35 Mn |
| Mar 31, 2020 | -2.60 Mn |
| Mar 31, 2020 | -2.60 Mn |
| Dec 31, 2019 | 1.69 Mn |
| Dec 31, 2019 | 1.69 Mn |
| Sep 30, 2019 | -1.13 Mn |
| Sep 30, 2019 | -1.13 Mn |
| Jun 30, 2019 | -2.25 Mn |
| Jun 30, 2019 | -2.25 Mn |
| Mar 31, 2019 | 953,000.00 |
| Mar 31, 2019 | 953,000.00 |
| Dec 31, 2018 | -5.73 Mn |
| Dec 31, 2018 | -5.73 Mn |
| Sep 30, 2018 | 7.56 Mn |
| Sep 30, 2018 | 7.56 Mn |
| Jun 30, 2018 | -1.46 Mn |
| Jun 30, 2018 | -1.46 Mn |
| Mar 31, 2018 | -759,000.00 |
| Mar 31, 2018 | -759,000.00 |
| Dec 31, 2017 | 2.37 Mn |
| Dec 31, 2017 | 2.37 Mn |
| Sep 30, 2017 | 4.14 Mn |
| Sep 30, 2017 | 4.14 Mn |
| Jun 30, 2017 | -2.18 Mn |
| Jun 30, 2017 | -2.18 Mn |
| Mar 31, 2017 | 1.96 Mn |
| Mar 31, 2017 | 1.96 Mn |
| Dec 31, 2016 | -2.02 Mn |
| Dec 31, 2016 | -2.02 Mn |
| Sep 30, 2016 | 2.23 Mn |
| Sep 30, 2016 | 2.23 Mn |
| Jun 30, 2016 | -1,000.00 |
| Jun 30, 2016 | -1,000.00 |
| Mar 31, 2016 | 757,000.00 |
| Mar 31, 2016 | 757,000.00 |
| Dec 31, 2015 | -415,000.00 |
| Dec 31, 2015 | -415,000.00 |
| Sep 30, 2015 | -620,000.00 |
| Sep 30, 2015 | -620,000.00 |
| Jun 30, 2015 | 1.32 Mn |
| Jun 30, 2015 | 1.32 Mn |
| Mar 31, 2015 | -850,000.00 |
| Mar 31, 2015 | -850,000.00 |
| Dec 31, 2014 | -74,000.00 |
| Dec 31, 2014 | -74,000.00 |
| Sep 30, 2014 | -635,000.00 |
| Sep 30, 2014 | -635,000.00 |
| Jun 30, 2014 | -1.07 Mn |
| Jun 30, 2014 | -1.07 Mn |
| Mar 31, 2014 | 1.29 Mn |
| Mar 31, 2014 | 1.29 Mn |
| Dec 31, 2013 | 44,000.00 |
| Dec 31, 2013 | 44,000.00 |
| Sep 30, 2013 | -696,000.00 |
| Sep 30, 2013 | -696,000.00 |
| Jun 30, 2013 | 770,000.00 |
| Jun 30, 2013 | 770,000.00 |
| Mar 31, 2013 | -1.54 Mn |
| Mar 31, 2013 | -1.54 Mn |
| Dec 31, 2012 | 2.23 Mn |
| Dec 31, 2012 | 2.23 Mn |
| Sep 30, 2012 | -2.66 Mn |
| Sep 30, 2012 | -2.66 Mn |
| Jun 30, 2012 | 2.15 Mn |
| Jun 30, 2012 | 2.15 Mn |
| Mar 31, 2012 | -1.53 Mn |
| Mar 31, 2012 | -1.53 Mn |
| Dec 31, 2011 | 2.55 Mn |
| Dec 31, 2011 | 2.55 Mn |
| Sep 30, 2011 | -1.23 Mn |
| Sep 30, 2011 | -1.23 Mn |
| Jun 30, 2011 | 426,000.00 |
| Jun 30, 2011 | 426,000.00 |
| Mar 31, 2011 | 1.05 Mn |
| Mar 31, 2011 | 1.05 Mn |
| Dec 31, 2010 | -860,000.00 |
| Dec 31, 2010 | -860,000.00 |
| Sep 30, 2010 | 504,000.00 |
| Sep 30, 2010 | 504,000.00 |